Expert Reports and Articles

IN HEALTH, FOOD AND WELL-BEING
The following list presents expert reports and publications conducted, facilitated and coordinated by the Global Experts Foundation
Expert reports
Recently Released
Dutch Expert Report
Clinical relevance & patient relevance of a Treat-and-Extend treatment regimen in ophthalmology for macular disorders
Publication date: 29 April 2022

Authors:
Dr. J.J.C. van Lith-Verhoeven
Prof. Dr. R.O. Schlingemann
H.M.M.J. Schoots-Wilke

Location: Woerden, the Netherlands, April 29, 2022

ISBN: 978-94-91526-97-8
Expert reports
Health Care Reports
Dutch Expert Report
Klinische relevantie & patiëntenrelevantie van een Treat-and-Extend beleid in de oogheelkunde bij macula aandoeningen
Woerden, the Netherlands, April 29, 2022;
ISBN: 978-94-91526-97-8.
Dutch Expert Report
Consensus Diagnosis and Treatment of NTRK Fusion-Positive Solid Tumors.
NL: Consensus Diagnose en Behandeling van NTRK-genfusie gerelateerde Solide Tumoren.

Woerden, the Netherlands, February 14, 2020; ISBN: 978-94-91526-11-4.
Dutch Expert Report
The Patient-perspective on Access to Sight-Saving Eye-Injections for Macula Disorders
NL: Het patiëntenperspectief op de toegankelijkheid tot oog-injecties bij netvliesafwijkingen

Woerden, the Netherlands, October 24, 2017; ISBN: 978-94-91526-10-7.
Also published by the following supporting organizations: www.oogvereniging.nl; www.maculavereniging.nl; www.oogheelkunde.org; www.dvn.nl; www.oogfonds.nl; www.diabetesfonds.nl; www.ephor.eu; www.kbo-pcob.nl
English Expert Report
Health Relevance of Vaccination in Older People. Medical Need, (Cost-)Effectiveness & Implementation. Herpes Zoster Vaccination as an example.
Munich, Germany, November 16, 2016; ISBN: 978-94-91526-09-1.
Also published by the following supporting organizations: www.ephor.eu, www.vlaamse-ouderenraad.be, www.bop.brussels
Dutch Expert Report
Clinical Relevance of Therapeutic Alternatives. Illustrated for: vascular macula disorders
NL: Klinische Relevantie van Therapeutische Alternatieven. Toegelicht bij: vasculaire aandoeningen van de macula

Munich, Germany, October 31, 2016; ISBN: 978-94-91526-08-4.
Also published by the following supporting organization: www.ephor.eu
English Expert Report
Clinical relevance and patient relevance of delayed-release cysteamine bitartrate for patients with nephropathic cystinosis.
Clinical and patient/caregiver perspective.

Munich, Germany, 16 March, 2016; ISBN: 978-94-91526-07-7.
English Expert Report
Health Relevance of Shingles Vaccination in the Elderly Population. Medical Need, (Cost-)Effectiveness & Implementation.
NL: De Gezondheidsrelevantie van gordelroos vaccinatie bij ouderen. Medische noodzaak, (Kosten-)Effectiviteit & Implementatie.

Munich, Germany, September 9, 2015; ISBN: 978-94-91526-06-0.
Also published by the following supporting organization: www.ephor.eu
English Expert Report
Economic relevance and validation procedure. Clostridium difficile Infections.
Determination and validation of relevant issues in cost-effectiveness evaluation. Guidance on the integration of these issues into the cost-effectiveness model.

Munich, Germany, March 14, 2014, ISBN: 978-94-91526-05-3.
English Expert Report
Economic relevance and validation procedure. Orphan Medicinal Products. Determination of relevant issues in the cost-effectiveness evaluation.
Role of cost-effectiveness evaluation and other economic instruments in current coverage decisions. Guidance on coverage decision-making in orphan disease: an algorithmic approach.

Munich, Germany, February 28, 2014, ISBN: 978-94-91526-04-6.
Dutch Expert Report
The patient-perspective on anticoagulant therapy of deep venous thrombosis and pulmonary embolism.
NL: Het patiёntenperspectief op antistollingsbehandeling van diep veneuze trombose en longembolie (VTE).

Munich, Germany, October 9, 2013, ISBN: 978-94-91526-03-9.
Also published by the following supporting organizations: www.ephor.nl, www.hartenvaatgroep.nl, www.nvhvv.nl, October 2013
English & Dutch Expert Report
Treatment of non-valvular atrial fibrillation with oral anticoagulantia, Clinical Relevance and Validationprocedure.
NL: Behandeling van non-valvulair atrium fibrilleren met orale coagulantia.

Munich, Germany, 18 July, 2012, ISBN: 978-94-91526-01-5.
Also published by the following supporting organizations: www.ephor.nl, www.hartenvaatgroep.nl, www.nvhvv.nl, August 2012.
English & Dutch Expert Report
The patient-perspective on treatment with oral anticoagulantia.
NL: Het patiëntenperspectief op de behandeling met orale antistollingsmiddelen bij atrium fibrilleren.

Clinical Relevance and Validationprocedure. Munich, Germany, 23 May, 2012, ISBN: 978-94-91526-00-8.
Also published by the following supporting organizations: www.ephor.nl, www.medicijngebruik.nl, www.hartenvaatgroep.nl, www.nvhvv.nl, June 2012.
Dutch Expert Report
Expert Report: Procedure on orthopedic surgery.
National expert procedure. Munich, Germany, 26 October, 2010.
Dutch Expert Report
Standpunt: Intra-arteriële radioembolisatie voor de behandeling van colorectale levermetastasen.
Munich, Germany, 1 May, 2013.
Dutch Expert Report
Clinical relevance of lipid based formulations of amphotericin B in severe fungal infections.
Munich, Germany, 15 November, 2011.
European Expert Report
Procedure on 'Treatment approach of Alpha1-Antitrypsine Deficiency (AATD)'.
Munich, Germany, 31 January, 2011.
Dutch Expert Report
National Expert Procedure on Pain Management.
Munich, Germany, 26 June, 2009.
Expert reports
Food and Well-Being
Expert Report from Italy
Chill-Food Italia: Reconnecting children to the value of food for a sustainable future
Chill-Food Italia: Riconnettere i bambini al valore del cibo per un futuro sostenibile

Woerden, the Netherlands, October 13th, 2020; ISBN: 978-94-91526-71-8.
International Expert Report
The Decision-Growth Cycle: A model based on the real-world experiences of global young leaders
Bodegraven, the Netherlands, March 26, 2019; ISBN 978-94-91526-13-8.
Published articles
Health Care Publications
"Dual pathway inhibition has added value in patients with stable cardiovascular disease".
Dutch article: "Combinatietherapie heeft een toegevoegde waarde bij vaatziekte".
Hugo ten Cate, Bernard Elsman, Wiek van Gilst, Lisa de Jong, Hans van Laarhoven, Anho Liem en Michiel Warlé. Pharm Weekbl Aug 16, 2019: 154-33/34.
"Health Insurers restrict access to life-saving eye-injections for patients with macula disorders".
Dutch article: "Verzekeraars beknibbelen op reddende ooginjecties".
Newspaper 'Algemeen Dagblad', Oct. 24th, 2017.
"Clinical and economic issues complicating cost-effectiveness analysis of orphan diseases".
English article
Mark Nuijten, Marja Pronk, John Hutton, Peter van Hasselt, Cor Oosterwijk and Frans Rutten. The Eurobiotech Journal 2017:1(2):132-7.
"Cost-effectiveness in Clostridium difficile treatment decision-making".
English article
Mark JC Nuijten, Josbert J Keller, Caroline E Visster, Ken Redekop, Eric Claassen, Peter Speelman, Marja H Pronk. World J Clin Cases 2015 November 16:3(11):935-941.
"Patient-perspective in the reimbursement assessment of direct anticoagulant products for atrial fibrillation and venous thromboembolism".
Dutch article: "Patiëntenperspectief in de beoordeling van direct werkende orale anticoagulantia bij atriumfibrilleren en veneuze trombo-embolie".
Koos Brouwers, Jeroen Hendriks, Hans van Laarhoven, Gerlof Jukema, Marja Pronk. Pharm Weekbl 2015:9(4):72-2.
"Stimulate the release of new innovations'. Health addendum to daily national journal".
Dutch article: "Introductie nieuwe middelen kan sneller".
Newspaper 'Telegraaf', August 2012.
"Recommendations about oral anticoagulantia".
Dutch article: "Aanbevelingen over orale anticoagulantia."
Koos J.R.B.J. Brouwers, Ele Visser and Maarten J. Beinema. NTvG. July 2012;156:A5123.
"Take patient experience into account".
Dutch article
Koos Brouwers, Pharmaceutisch Weekblad, June 2012.
"The voice of the patient must be heard. Health addendum to daily national journal."
Dutch article: "Stem van de patiënt moet meewegen".
Newspaper 'Telegraaf', June 2012.